Identification of Protein Markers Predictive of Drug-Specific Survival Outcome in Cancers
Identification of Protein Markers Predictive of Drug-Specific Survival Outcome in Cancers
复制标题
DOI:
10.1007/978-3-030-91415-8_6
复制
发表时间:
2021
影响因子:
9.2
通讯作者:
Shuting Lin;Jie-Chao Zhou;Yiqiong Xiao;B. Neary;Yong Teng;Peng-Chao Qiu
中科院分区:
文献类型:
--
作者:
Shuting Lin;Jie-Chao Zhou;Yiqiong Xiao;B. Neary;Yong Teng;Peng-Chao Qiu
Novel discoveries of biomarkers predictive of drug-specific responses not only play a pivotal role in revealing the drug mechanisms in cancers, but are also critical to personalized medicine. In this study, we identified drug-specific biomarkers by integrating protein expression data, drug treatment data and survival outcome of 7076 patients from The Cancer Genome Atlas (TCGA). We first defined cancer-drug groups, where each cancer-drug group contains patients with the same cancer and treated with the same drug. For each protein, we stratified the patients in each cancer-drug group by high or low expression of the protein, and applied log-rank test to examine whether the stratified patients show significant survival difference. We examined 336 proteins in 98 cancer-drug groups and identified 65 protein-cancer-drug combinations involving 55 unique proteins, where the protein expression levels are predictive of drug-specific survival outcomes. Some of the identified proteins were supported by published literature. Using the gene expression data from TCGA, we found the mRNA expression of11% of the drug-specific proteins also showed significant correlation with drug-specific survival, and most of these drug-specific proteins and their corresponding genes are strongly correlated.